cetylpyridinium chloride anhydrous has been researched along with captopril in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergenfelz, A; Isaksson, A; Valdemarsson, S; Westerdahl, C | 1 |
1 trial(s) available for cetylpyridinium chloride anhydrous and captopril
| Article | Year |
|---|---|
Captopril suppression: limitations for confirmation of primary aldosteronism.
Topics: Adult; Aldosterone; Antihypertensive Agents; Captopril; Female; Health; Humans; Hyperaldosteronism; Male; Renin; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Young Adult | 2011 |